GILEAD SCIENCES, INC. - 27 Mar 2024 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
10%+ Owner
Signature
Gilead Sciences, Inc. By: /s/ Andrew Dickinson
Issuer symbol
XLO
Transactions as of
27 Mar 2024
Net transactions value
$0
Form type
3
Filing time
03 Apr 2024, 18:48:44 UTC
Previous filing
13 Feb 2024
Next filing
03 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XLO Common Stock 6,860,223 27 Mar 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.